Neuroprotective effects of astaxanthin in a rat model of spinal cord injury

Behavioural Brain Research

Volumn 329, Issue , 2017, Pages 104-110

  Masoudi, Alireza ^a   Dargahi, Leila ^a   Abbaszadeh, Fatemeh ^a   Pourgholami, Mohammad Hosein ^a   Asgari, Alireza ^b,c   Manoochehri, Mehdi ^d   Jorjani, Masoumeh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AJA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHROUD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Astaxanthin; Neuroprotection; Spinal cord injury

Indexed keywords

ASTAXANTHIN; CASPASE 3; PROTEIN BAX; PROTEIN BCL 2; NEUROPROTECTIVE AGENT; XANTHOPHYLL;

ADULT; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; DISEASE SEVERITY; LAMINECTOMY; LIPOPHILICITY; MALE; MOTOR PERFORMANCE; MYELINATION; NEUROPROTECTION; NONHUMAN; OXYGENATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY; ANIMAL; DISEASE MODEL; DRUG EFFECTS; LOCOMOTION; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; SPINAL CORD; TIME FACTOR; WISTAR RAT;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; DISEASE MODELS, ANIMAL; LOCOMOTION; MALE; NEURONS; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; SPINAL CORD; SPINAL CORD INJURIES; TIME FACTORS; XANTHOPHYLLS;

EID: 85018967221     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2017.04.026     Document Type: Article

References (82)

1. [1] Silva, N.A., et al. From basics to clinical: a comprehensive review on spinal cord injury. Prog. Neurobiol. 114 (2014), 25–57.
2. [2] Tsuchida, M., et al. PACAP stimulates functional recovery after spinal cord injury through axonal regeneration. J. Mol. Neurosci. 54:3 (2014), 380–387.
3. [3] Su, Z., et al. In vivo conversion of astrocytes to neurons in the injured adult spinal cord. Nat. Commun., 5, 2014.
4. [4] Nagai, J., et al. Crmp4 deletion promotes recovery from spinal cord injury by neuroprotection and limited scar formation. Sci. Rep., 5, 2015.
5. [5] Shul'ga, A., et al. Modern aspects of pathogenesis of the trauma of the spinal cord and trunks of peripheral nerves. Ross Fiziol Zh Im I M Sechenova 100:2 (2014), 145–160.
6. [6] Ormond, D.R., et al. Recovery from spinal cord injury using naturally occurring antiinflammatory compound curcumin: laboratory investigation. J. Neurosurg. Spine 16:5 (2012), 497–503.
7. [7] Cruz, C.D., et al. Biomarkers of spinal cord injury and ensuing bladder dysfunction. Adv. Drug. Deliv. Rev. 82 (2015), 153–159.
8. [8] Fatima, G., et al. Oxidative stress and antioxidative parameters in patients with spinal cord injury: implications in the pathogenesis of disease. Spin. Cord 53:1 (2015), 3–6.
9. [9] Ghanbari, A., et al. In vivo microdialysis of glutamate in ventroposterolateral nucleus of thalamus following electrolytic lesion of spinothalamic tract in rats. Exp. Brain Res. 232:2 (2014), 415–421.
10. [10] Faden, A.I., et al. Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury. Br. J. Pharmacol. 173:4 (2016), 681–691.
11. [11] Hall, E.D., et al. Lipid peroxidation in brain or spinal cord mitochondria after injury. J. Bioenerg. Biomembr. 48:2 (2016), 169–174.
12. [12] Costa, P., et al. Neurophysiological assessment of the injured spinal cord: an intraoperative approach. Spin. Cord 2:10 (2014), 749–757.
13. [13] Wu, Y., et al. Delayed post-injury administration of riluzole is neuroprotective in a preclinical rodent model of cervical spinal cord injury. J. Neurotrauma 30:6 (2013), 441–452.
14. [14] Chu, W., et al. Valproic acid arrests proliferation but promotes neuronal differentiation of adult spinal NSPCs from SCI rats. Neurochem. Res. 40:7 (2015), 1472–1486.
15. [15] Chen, W.F., et al. Neuroprotective effects of direct intrathecal administration of granulocyte colony-stimulating factor in rats with spinal cord injury. CNS Neurosci. Ther. 21:9 (2015), 698–707.
16. [16] Hall, E.D., Methylprednisolone for the treatment of patients with acute spinal cord injuries: a propensity score-matched cohort study from a canadian multi-center spinal cord injury registry. J. Neurotrauma 33:10 (2016), 972–974.
17. [17] Jongen, P.J., et al. Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse. J. Neurol., 2016, 1–11.
18. [18] Bastani, N.E., et al. Reduced antioxidant defense and increased oxidative stress in spinal cord injured patients. Arch. Phys. Med. Rehabil. 93:12 (2012), 2223–2228 e2.
19. [19] Choi, H.D., et al. Pharmacokinetics and first-pass metabolism of astaxanthin in rats. Br. J. Nutr. 105:02 (2011), 220–227.
20. [20] Fassett, R.G., Coombes, J.S., Astaxanthin, oxidative stress, inflammation and cardiovascular disease. Future Cardiol. 5:4 (2009), 333–342.
21. [21] Shen, H., et al. Astaxanthin reduces ischemic brain injury in adult rats. FASEB J. 3:6 (2009), 1958–1968.
22. [22] Ambati, R.R., et al. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications – a review. Mar. Drugs 12:1 (2014), 128–152.
23. [23] Guerin, M., Huntley, M.E., Olaizola, M., Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol. 21:5 (2003), 210–216.
24. [24] Kidd, P., Astaxanthin, cell membrane nutrient with diverseclinical benefits and anti-aging potential. Altern. Med. Rev. 16:4 (2011), 355–364.
25. [25] Ikeda, Y., et al. Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. J. Neurochem. 107:6 (2008), 1730–1740.
26. [26] Lu, Y., et al. Astaxanthin rescues neuron loss and attenuates oxidative stress induced by amygdala kindling in adult rat hippocampus. Neurosci. Lett. 597 (2015), 49–53.
27. [27] Kupcinskas, L., et al. Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: a prospective, randomized, double blind, and placebo-controlled study. Phytomedicine 15:6 (2008), 391–399.
28. [28] Park, J.S., et al. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutr. Metab. (Lond.), 7(1), 2010, 1.
29. [29] Song, X., et al. Astaxanthin inhibits apoptosis in alveolar epithelial cells type II in vivo and in vitro through the ROS-dependent mitochondrial signalling pathway. J. Cell. Mol. Med. 18:11 (2014), 2198–2212.
30. [30] Lin, T.Y., Lu, C.W., Wang, S.J., Astaxanthin inhibits glutamate release in rat cerebral cortex nerve terminals via suppression of voltage-dependent Ca2+ entry and mitogen-activated protein kinase signaling pathway. J. Agric. Food Chem. 58:14 (2010), 8271–8278.
31. [31] Kim, J.-H., et al. Astaxanthin inhibits H2O2-mediated apoptotic cell death in mouse neural progenitor cells via modulation of P38 and MEK signaling pathways. J. Microbiol. Biotechnol. 19:11 (2009), 1355–1363.
32. [32] Chan, K.C., Mong, M.C., Yin, M.C.C., Antioxidative and Anti‐Inflammatory neuroprotective effects of astaxanthin and canthaxanthin in nerve growth factor differentiated PC12Cells. J. Food Sci. 74:7 (2009), H225–H231.
33. [33] Liu, X., Osawa, T., Astaxanthin protects neuronal cells against oxidative damage and is a potent candidate for brain food. Forum Nutr., 2009.
34. [34] Liu, X., et al. Astaxanthin inhibits reactive oxygen species-mediated cellular toxicity in dopaminergic SH-SY5Y cells via mitochondria-targeted protective mechanism. Brain Res. 1254 (2009), 18–27.
35. [35] Zheng, D., et al. The protective effect of astaxanthin on fetal alcohol spectrum disorder in mice. Neuropharmacology 84 (2014), 13–18.
36. [36] Wu, W., et al. Astaxanthin alleviates brain aging in rats by attenuating oxidative stress and increasing BDNF levels. Food. Funct. 5:1 (2014), 158–166.
37. [37] Zhou, L., et al. Protective effect of astaxanthin against multiple organ injury in a rat model of sepsis. J. Surg. Res. 195:2 (2015), 559–567.
38. [38] Chen, W.-P., et al. Astaxanthin reduces matrix metalloproteinase expression in human chondrocytes. Int. Immunopharmacol. 19:1 (2014), 174–177.
39. [39] Chang, C.-H., et al. Astaxanthine secured apoptotic death of PC12 cells induced by β-amyloid peptide 25–35: its molecular action targets. J. Med. Food 13:3 (2010), 548–556.
40. [40] Al-Amin, M.M., et al. Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism. Behav. Brain Res. 286 (2015), 112–121.
41. [41] GRUNER, J.A., A monitored contusion model of spinal cord injury in the rat. J. Neurotrauma 9:2 (1992), 123–128.
42. [42] Mestre, C., et al. A method to perform direct transcutaneous intrathecal injection in rats. J. Pharmacol. Toxicol. Methods 32:4 (1994), 197–200.
43. [43] Zhang, X.-S., et al. Amelioration of oxidative stress and protection against early brain injury by astaxanthin after experimental subarachnoid hemorrhage: laboratory investigation. J. Neurosurg. 121:1 (2014), 42–54.
44. [44] Basso, D.M., Beattie, M.S., Bresnahan, J.C., A sensitive and reliable locomotorrating scale for open field testing in rats. J. Neurotrauma 12:1 (1995), 1–21.
45. [45] Naseri, K., et al. Role of microglia and astrocyte in central pain syndrome following electrolytic lesion at the spinothalamic tract in rats. J. Mol. Neurosci. 49 (2013), 470–479.
46. [46] Nakae, A., et al. The Animal Model of Spinal Cord Injury as an Experimental Pain Model. 2011, BioMed Research International.
47. [47] Sharif-Alhoseini, M., Rahimi-Movaghar, V., Animal Models in Traumatic Spinal Cord Injury. 2014, Topics in Paraplegia InTech.
48. [48] Yuan, J., Yankner, B.A., Apoptosis in the nervous system. Nature 07:6805 (2000), 802–809.
49. [49] Wu, H.-J., et al. The molecular mechanisms between autophagy and apoptosis: potential role in central nervous system disorders. Cell. Mol. Neurobiol. 35:1 (2015), 85–99.
50. [50] Tang, P., et al. Autophagy reduces neuronal damage and promotes locomotor recovery via inhibition of apoptosis after spinal cord injury in rats. Mol. Neurobiol. 49:1 (2014), 276–287.
51. [51] Abdul-Muneer, P.M., Chandra, N., Haorah, J., Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury. Mol. Neurobiol. 51:3 (2015), 966–979.
52. [52] Visavadiya, N.P., et al. Cellular and subcellular oxidative stress parameters following severe spinal cordinjury. Redox Biol. 8 (2016), 59–67.
53. [53] Rodriguez-Rodriguez, A., et al. Oxidative stress in traumatic brain injury. Curr. Med. Chem. 21:10 (2014), 1201–1211.
54. [54] Sakurai, M., et al. Survival and death-promoting events after transient spinal cord ischemia in rabbits: induction of Akt and caspase3 in motor neurons. J. Thorac. Cardiovasc. Surg. 125:2 (2003), 370–377.
55. [55] Zhang, N., et al. Inflammation & apoptosis in spinal cord injury. Indian J. Med. Res., 135(3), 2012, 287.
56. [56] Ozdemir, U.S., et al. Hypericum perforatum attenuates spinal cord injury-induced oxidative stress and apoptosis in the dorsal root ganglion of rats: involvement of TRPM2 and TRPV1 channels. Mol. Neurobiol., 2015, 1–12.
57. [57] Luo, Y., et al. Mangiferin attenuates contusive spinal cord injury in rats through the regulation of oxidative stress, inflammation and the Bcl-2 and Bax pathway. Mol. Med. Rep. 12:5 (2015), 7132–7138.
58. [58] Chen, H., et al. Effects of the combined administration of vitamins C and Eon the oxidative stress status and programmed cell death pathways after experimental spinal cord injury. Spin. Cord 2:1 (2014), 24–28.
59. [59] Wang, W.-G., et al. Protective effects of Vitamin C against spinal cord injury-induced renal damage through suppression of NF-κB and proinflammatory cytokines. Neurol. Sci. 36:4 (2015), 521–526.
60. [60] Robert, A.A., et al. The efficacy of antioxidants in functional recovery of spinal cord injured rats: an experimental study. Neurol. Sci. 33:4 (2012), 785–791.
61. [61] Yan, M., et al. High-dose ascorbic acid administration improves functional recovery in rats with spinal cord contusion injury. Spin. Cord 52:11 (2014), 803–808.
62. [62] Lee, J.Y., Choi, H.Y., Yune, T.Y., Fluoxetine and vitamin C synergistically inhibits blood-spinal cordbarrier disruption and improves functional recovery after spinal cord injury. Neuropharmacology, 2016.
63. [63] Liu, C., et al. Resveratrol improves neuron protection and functional recovery in rat model of spinal cord injury. Brain Res. 1374 (2011), 100–109.
64. [64] Ciftci, U., et al. Efficiacy of resveratrol and quercetin after experimental spinal cord injury. Ulus Travma Acil Cerrahi Derg 22:5 (2016), 423–431.
65. [65] Du, F., et al. Gastrodin ameliorates spinal cord injury via antioxidant and anti-inflammatory effects. Acta Biochim. Pol., 63(3), 2016.
66. [66] Aydemir, S., et al. The effect of melatonin on spinal cord after ischemia in rats. Spin. Cord, 2015.
67. [67] Samantaray, S., et al. Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats. J. Pineal Res. 44:4 (2008), 348–357.
68. [68] Yao, M., et al. Neurological recovery and antioxidant effects of curcumin for spinal cord injury in the rat: a network meta-analysis and systematic review. J. Neurotrauma 32:6 (2015), 381–391.
69. [69] Yu, H., et al. Protective effect of curcumin on neural myelin sheaths by attenuating interactions between the Endoplasmic reticulum and Mitochondria after compressed spinal cord. J. Spine, 5(322), 2016, 2.
70. [70] Cemil, B., et al. Curcumin improves early functional results after experimental spinal cord injury. Acta Neurochir. (Wien) 152:9 (2010), 1583–1590.
71. [71] Mosquera, L., et al. Tamoxifen and estradiol improved locomotor function and increased spared tissue in rats after spinal cord injury: their antioxidant effect and role of estrogen receptor alpha. Brain Res. 1561 (2014), 11–22.
72. [72] Bai, W., et al. The effect of astaxanthin (AST) on Neurotrophin-3 (NT-3) expression in rats after compressive spinal cord injury (SCI). Afr. J. Pharm. Pharmacol. 6:34 (2012), 2559–2564.
73. [73] Yamagishi, R., Aihara, M., Neuroprotective effect of astaxanthin against rat retinal ganglion cell death under various stresses that induce apoptosis and necrosis. Mol. Vis.(20), 2014.
74. [74] Li, Z., et al. Astaxanthin protects ARPE-19 cells from oxidative stress via upregulation of Nrf2-regulated phase II enzymes through activation of PI3K/Akt. Mol. Vis.(25), 2013, 1656–1666.
75. [75] Dong, L.-Y., et al. Astaxanthin attenuates the apoptosis of retinal ganglion cells in db/db mice by inhibition of oxidative stress. Mar. Drugs 11:3 (2013), 960–974.
76. [76] Lee, D.-H., Lee, Y.J., Kwon, K.H., Neuroprotective effects of astaxanthin in oxygen-glucose deprivation in SH-SY5Y cells and global cerebral ischemia in rat. J. Clin. Biochem. Nutr. 47:2 (2010), 121–129.
77. [77] Kim, J.H., et al. Astaxanthin inhibits H2O2-mediated apoptotic cell death in mouse neural progenitor cells via modulation of P38 and MEK signaling pathways. J. Microbiol. Biotechnol. 19:11 (2009), 1355–1363.
78. [78] Lu, Y.P., et al. Neuroprotective effect of astaxanthin on H 2 O 2-induced neurotoxicity in vitro and on focal cerebral ischemia in vivo. Brain Res. 1360 (2010), 40–48.
79. [79] Zhang, X.-S., et al. Astaxanthin alleviates early brain injury following subarachnoid hemorrhage in rats: possible involvement of Akt/bad signaling. Mar. Drugs 12:8 (2014), 4291–4310.
80. [80] Wu, Q., et al. Astaxanthin activates nuclear factor erythroid-related factor 2 and the antioxidant responsive element (Nrf2-ARE) pathway in the brain after subarachnoid hemorrhage in rats and attenuates early brain injury. Mar. Drugs 12:12 (2014), 6125–6141.
81. [81] Wang, H.-Q., et al. Astaxanthin upregulates heme oxygenase-1 expression through ERK1/2 pathway and its protective effect against beta-amyloid-induced cytotoxicity in SH-SY5Y cells. Brain Res. 1360 (2010), 159–167.
82. [82] Lee, D.-H., Kim, C.-S., Lee, Y.J., Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro. Food. Chem. Toxicol. 49:1 (2011), 271–280.